Byambasuren Ganbaatar

Statistics

Publications

Citations

229

H-Index

Active since

2018

Affiliations

Tokushima University(Current)

Kobe University

Byambasuren Ganbaatar is an author at Tokushima University specializing in pharmacology, endothelial dysfunction, and vascular endothelial dysfunction.

Publications per year

2018–2024

Publications

Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice

Byambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara et al. · European Journal of Pharmacology · 2020 · 122 citations

Medicine, Pharmacology, Pharmacotherapy +14

Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice

Byambasuren Ganbaatar, Daiju Fukuda, Hotimah Masdan Salim et al. · Atherosclerosis · 2018 · 30 citations · Full text

Veterinary Medicine, Cardiology, Pharmacology +13

A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction in Diabetic C57BL/6 Mice

Uugantsetseg Munkhjargal, Daiju Fukuda, Byambasuren Ganbaatar et al. · Journal of Atherosclerosis and Thrombosis · 2022 · 20 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1

Mai Kanai, Byambasuren Ganbaatar, Itsuro Endo et al. · International Journal of Molecular Sciences · 2024 · 17 citations · Full text

Life Sciences, Immunology, Physiology +17

Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice

Byambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara et al. · Journal of Atherosclerosis and Thrombosis · 2020 · 14 citations · Full text

Life Sciences, Pharmacology, Physiology +14

1–5 of 7